<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0098">
 <element-citation publication-type="journal" id="sbref0098">
  <person-group person-group-type="author">
   <name>
    <surname>Park</surname>
    <given-names>H.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>Y.N.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y.J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>H.J.</given-names>
   </name>
   <name>
    <surname>Son</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>H.W.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Britanin suppresses LPS-induced nitric oxide, PGE2 and cytokine production via NF-ÎºB and MAPK inactivation in RAW 264.7 cells</article-title>
  <source>International Immunopharmacology</source>
  <volume>15</volume>
  <issue>2</issue>
  <year>2013</year>
  <fpage>296</fpage>
  <lpage>302</lpage>
  <pub-id pub-id-type="doi">10.1016/j.intimp.2012.12.005</pub-id>
  <pub-id pub-id-type="pmid">23270759</pub-id>
 </element-citation>
</ref>
